a year ago
BMRN
AnalystsMitchell S. KapoorMitchell S. Kapoor's Stock Forecasts
AnalystsMitchell S. Kapoor
Sectors:
Industries:
Analyst Ranking
Top 19%
#1009 out of 5550 analysts
Average Return
+4.52%
Win Rate
44%76 out of 172
Risk vs Reward
Poor
Good
Mitchell S. Kapoor's 5 best and worst ratings
| Name / Ticker | Gain/Loss | Entry Price | Exit Price | Period | Rating |
|---|---|---|---|---|---|
Oruka Therapeutics IncORKA | +638.75% | $15.25 | $112.66 | 2025-08-18 - 2026-08-17 | Buy |
Alumis IncALMS | +420.96% | $4.39 | $22.87 | 2025-08-14 - 2026-05-15 | Buy |
Oruka Therapeutics IncORKA | +226.10% | $27.70 | $90.33 | 2025-10-27 - 2026-10-26 | Buy |
Boundless Bio IncBOLD | +154.05% | $1.11 | $2.82 | 2025-08-11 - 2026-08-10 | Buy |
Kyverna Therapeutics IncKYTX | +125.61% | $3.71 | $8.37 | 2025-08-29 - 2026-08-28 | Buy |
Mitchell S. Kapoor Analyst Color
Get additional color on Mitchell S. Kapoor's coverage of popular stocks
a year ago
BMRN
Mitchell S. Kapoor's Stock Coverage
| Name / Ticker | No. Ratings | Rating | Price Target | Upside/Downside | Action | Date |
|---|---|---|---|---|---|---|
Atrium Therapeutics IncRNA | 3 | Buy | $20.00 | +141.84% | Maintains | 4 days ago |
Neurogene IncNGNE | 7 | Buy | $65.00 | +135.93% | Reiterates | 4 days ago |
Avalo Therapeutics IncAVTX | 6 | Hold | N/A | N/A | Downgrades | 9 days ago |
Crescent Biopharma IncCBIO | 6 | Buy | $36.00 | +167.06% | Reiterates | 13 days ago |
Palisade Bio IncPALI | 3 | Buy | $7.00 | +503.45% | Reiterates | 19 days ago |
Incyte CorpINCY | 17 | Buy | $152.00 | +26.26% | Reiterates | 19 days ago |
Halozyme Therapeutics IncHALO | 10 | Buy | $130.00 | -0.70% | Maintains | 24 days ago |
Korro Bio IncKRRO | 6 | Buy | $15.00 | +4.79% | Reiterates | a month ago |
Sarepta Therapeutics IncSRPT | 6 | Sell | $5.00 | -73.15% | Reiterates | a month ago |
Monte Rosa Therapeutics IncGLUE | 2 | Buy | $25.00 | +132.34% | Reiterates | a month ago |
Generate Biomedicines IncGENB | 5 | Buy | $30.00 | +107.47% | Reiterates | a month ago |
Legend Biotech CorpLEGN | 9 | Buy | $65.00 | +200.51% | Reiterates | a month ago |
Cartesian Therapeutics IncRNAC | 3 | Buy | $25.00 | +285.21% | Reiterates | a month ago |
Oruka Therapeutics IncORKA | 9 | Buy | $120.00 | +23.88% | Reiterates | a month ago |
Ionis Pharmaceuticals IncIONS | 16 | Buy | $100.00 | +129.78% | Reiterates | a month ago |
Summit Therapeutics IncSMMT | 14 | Hold | N/A | N/A | Reiterates | a month ago |
Tyra Biosciences IncTYRA | 6 | Buy | $29.00 | +37.64% | Maintains | a month ago |
Biomarin Pharmaceutical IncBMRN | 11 | Hold | $60.00 | +2.55% | Reiterates | 2 months ago |
Intellia Therapeutics IncNTLA | 10 | Buy | $25.00 | +100.48% | Reiterates | 2 months ago |
Evommune IncEVMN | 6 | Hold | N/A | N/A | Reiterates | 2 months ago |
Scribe Therapeutics IncSCTX | 2 | Buy | $60.00 | +289.11% | Reiterates | 2 months ago |
Alumis IncALMS | 8 | Buy | $15.00 | +122.88% | Upgrades | 2 months ago |
Ascendis Pharma AASND | 2 | Buy | $344.00 | +36.90% | Maintains | 2 months ago |
Damora Therapeutics IncDMRA | 2 | Buy | $45.00 | +109.40% | Reiterates | 3 months ago |
Meiragtx Holdings PLCMGTX | 2 | Buy | $20.00 | +110.75% | Reiterates | 4 months ago |
Crispr Therapeutics AgCRSP | 2 | Buy | $80.00 | +55.58% | Reiterates | 4 months ago |
Lyell Immunopharma IncLYEL | 4 | Buy | $45.00 | +307.61% | Reiterates | 5 months ago |
Kyverna Therapeutics IncKYTX | 5 | Buy | $25.00 | +340.92% | Reiterates | 5 months ago |
Cytomx Therapeutics IncCTMX | 3 | Buy | $11.00 | +370.09% | Maintains | 6 months ago |
Century Therapeutics IncIPSC | 1 | Buy | $5.00 | +240.14% | Maintains | 6 months ago |
Lexeo Therapeutics IncLXEO | 4 | Buy | $10.00 | +218.47% | Maintains | 10 months ago |
Instil Bio IncTIL | 4 | Hold | N/A | N/A | Downgrades | 10 months ago |
Editas Medicine IncEDIT | 2 | Buy | $5.00 | N/A | Reiterates | a year ago |
Metagenomi Therapeutics IncMGX | 1 | Buy | $7.00 | N/A | Reiterates | a year ago |
Zura Bio LtdZURA | 1 | Hold | $2.00 | N/A | Maintains | a year ago |
Boundless Bio IncBOLD | 1 | Buy | $4.00 | N/A | Maintains | a year ago |
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.